The anticonvulsant effect of the dihydropyridine calcium channel block
er, nimodipine (NMD) was evaluated against electroshock-induced seizur
es in mice. At 1 h postdosing, NMD elicited a dose-dependent reduction
in the occurrence of tonic hindlimb extension (THE) after maximal ele
ctroshock (MES). The calculated ED,, for NMD was 87 mg/kg. A single do
se of NMD (75 mg/kg) produced a significant (p < 0.05) reduction in oc
currence of THE for less than or equal to 12 h postdosing. NMD was det
ectable for less than or equal to 6 h, and plasma and brain drug conce
ntrations correlated well (r = 0.677, p < 0.01) for that period. At 1
h postdose, a single dose of NMD (75 mg/kg) produced a 40% increase (p
< 0.001) in the threshold for tonic seizures as determined by minimal
electroshock (Min-ES). NMD is an effective anticonvulsant against exp
erimental seizures induced by electroshock. The pharmacodynamic effect
of NMD appears to extend beyond the time anticipated from the pharmac
okinetic profile.